A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer
Clinical trial NCT04945733 · TERMINATED
Trial details
- NCT number
- NCT04945733
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2023-07-03
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.